Angelicola, S., Giunchi, F., Ruzzi, F., Frascino, M., Pitzalis, M., Scalambra, L., . . . Palladini, A. PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD). BMC.
Chicago Style (17th ed.) CitationAngelicola, Stefania, et al. PD-L1 and IFN-γ Modulate Non-Small Cell Lung Cancer (NSCLC) Cell Plasticity Associated to Immune Checkpoint Inhibitor (ICI)-mediated Hyperprogressive Disease (HPD). BMC.
MLA (9th ed.) CitationAngelicola, Stefania, et al. PD-L1 and IFN-γ Modulate Non-Small Cell Lung Cancer (NSCLC) Cell Plasticity Associated to Immune Checkpoint Inhibitor (ICI)-mediated Hyperprogressive Disease (HPD). BMC.
Warning: These citations may not always be 100% accurate.